Rear Adm. Krista Pedley, Director of the U.S. Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA), gave a brief update on the 340B program during yesterday’s 340B Coalition virtual summer conference. She explained that “due to current litigation in the program, I am unable to provide specifics concerning much of the work that is underway on the 340B program at HRSA.”
“We continue to work closely with HHS leadership on key priorities and will continue to provide updates to the extent that we are able,” Pedley said.
Rear Adm. Krista Pedley, Director of the U.S. Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs, gave a brief update on the 340B program during yesterday’s 340B Coalition virtual summer conference. She explained that “due to current litigation in the program, I am unable to provide specifics concerning much of the work that is underway on the 340B program at HRSA.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
